{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"Count of Participants with adverse events.","groups":[{"description":"Doxil, Thalidomide, Dexamethasone\n\nDoxil: Doxil 40 mg/m2 IV day 1\n\nThalidomide: 50-100 mg day 1-28\n\nDexamethasone: Dexamethasone 40 mg day 1-4 and 15-18","id":"OG000","title":"Arm 1"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"End of study, up to 12 months","title":"Toxicity","type":"SECONDARY","unitOfMeasure":"Participants"}